ORAJEL

This brand name is authorized in South Africa, UK.

Active ingredients

The drug ORAJEL contains one active pharmaceutical ingredient (API):

1
UNII U3RSY48JW5 - BENZOCAINE
 

Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited.
 
Read more about Benzocaine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ORAJEL Dental gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N01BA05 Benzocaine N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BA Esters of aminobenzoic acid
Discover more medicines within N01BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
GB Medicines & Healthcare Products Regulatory Agency 45104, 80638, 80654
ZA Health Products Regulatory Authority 28/4/0163

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈